Literature DB >> 17464925

Healthcare costs associated with hemodialysis catheter-related infections: a single-center experience.

Venkataraman Ramanathan1, Edwin J Chiu, Jim T Thomas, Ahmad Khan, George M Dolson, Rabih O Darouiche.   

Abstract

In patients undergoing hemodialysis, catheter-related bacteremia results in expensive hospitalizations. In our study, the mean cost was $23,451 per hospitalization. When itemized, housing ("bed-related") costs accounted for 66% of the total; laboratory costs accounted for 4%, radiologic costs accounted for 9%, and procedure-related costs accounted for 21%. Hypoalbuminemia and bacteremia due to methicillin-resistant Staphylococcus aureus (MRSA) are associated with higher healthcare costs; bacteremia due to MRSA is also associated with poor survival rates.

Entities:  

Mesh：

Year:  2007        PMID： 17464925     DOI： 10.1086/513617

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  10 in total

1.  Prevention of catheter-related infection: evidence-based medicine.

Authors:  Donald P Levine
Journal:  Curr Infect Dis Rep       Date:  2009-07       Impact factor: 3.725

2.  Catheter-related bloodstream infections.

Authors:  Tracie A Wilcox
Journal:  Semin Intervent Radiol       Date:  2009-06       Impact factor: 1.513

3.  An economic evaluation of rt-PA locking solution in dialysis catheters.

Authors:  Braden J Manns; Nairne Scott-Douglas; Marcello Tonelli; Pietro Ravani; Martine LeBlanc; Marc Dorval; Rachel Holden; Louise Moist; Charmaine Lok; Deborah Zimmerman; Flora Au; Brenda R Hemmelgarn
Journal:  J Am Soc Nephrol       Date:  2014-07-10       Impact factor: 10.121

4.  Catheter-related infections in chronic hemodialysis: a clinical and economic perspective.

Authors:  Gabriel Ştefan; Simona Stancu; Cristina Căpuşă; Oana Ramaiana Ailioaie; Gabriel Mircescu
Journal:  Int Urol Nephrol       Date:  2012-07-24       Impact factor: 2.370

Review 5.  Economic features of antibiotic resistance: the case of methicillin-resistant Staphylococcus aureus.

Authors:  Fernando Antonanzas; Carmen Lozano; Carmen Torres
Journal:  Pharmacoeconomics       Date:  2015-04       Impact factor: 4.981

6.  The Effect of Risk of Maturation Failure and Access Type on Arteriovenous Access-Related Costs among Hemodialysis Patients.

Authors:  Sarah D Kosa; Amiram Gafni; Lehana Thabane; Charmaine E Lok
Journal:  Kidney360       Date:  2020-03-13

7.  Aryl rhodanines specifically inhibit staphylococcal and enterococcal biofilm formation.

Authors:  Timothy J Opperman; Steven M Kwasny; John D Williams; Atiyya R Khan; Norton P Peet; Donald T Moir; Terry L Bowlin
Journal:  Antimicrob Agents Chemother       Date:  2009-08-03       Impact factor: 5.191

8.  Hemodialysis Infection Prevention Protocols Ontario-Shower Technique (HIPPO-ST): A Pilot Randomized Trial.

Authors:  S Daisy Kosa; Amiram Gafni; Andrew A House; JulieAnn Lawrence; Louise Moist; Bharat Nathoo; Paul Tam; Alicia Sarabia; Lehana Thabane; George Wu; Charmaine E Lok
Journal:  Kidney Int Rep       Date:  2016-11-08

9.  Initiation of maintenance hemodialysis through central venous catheters: study of patients' perceptions based on a structured questionnaire.

Authors:  Tanya T Tang; Murray L Levin; Shubhada N Ahya; Khaled Boobes; Muhammad H Hasan
Journal:  BMC Nephrol       Date:  2019-07-17       Impact factor: 2.388

10.  Clinical outcomes associated with the use of the NexSite hemodialysis catheter with new exit barrier technology: Results from a prospective, observational multi-center registry study.

Authors:  Jeffrey G Hoggard; Richard D Blair; Manuel Montero; Moustafa A Moustafa; Joseph Newman; Pablo E Pergola; Nathan Saucier; Clarence J Wheeler; Leonard A Mermel; John R Ross; Anatole D Beserab
Journal:  PLoS One       Date:  2019-10-07       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.